Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Treasury Shares (2023 - 2025)

Apyx Medical filings provide 3 years of Treasury Shares readings, the most recent being $2.1 million for Q4 2025.

  • On a quarterly basis, Treasury Shares changed 0.08% to $2.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 0.08% change, with the full-year FY2025 number at $2.1 million, changed 0.08% from a year prior.
  • Treasury Shares hit $2.1 million in Q4 2025 for Apyx Medical, roughly flat from $2.1 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.1 million in Q4 2025 to a low of $2.1 million in Q4 2023.
  • Median Treasury Shares over the past 3 years was $2.1 million (2024), compared with a mean of $2.1 million.
  • Biggest five-year swings in Treasury Shares: rose 3.16% in 2024 and later rose 0.08% in 2025.
  • Apyx Medical's Treasury Shares stood at $2.1 million in 2023, then rose by 3.16% to $2.1 million in 2024, then grew by 0.08% to $2.1 million in 2025.
  • The last three reported values for Treasury Shares were $2.1 million (Q4 2025), $2.1 million (Q4 2024), and $2.1 million (Q4 2023) per Business Quant data.